LRSPX
Price
$14.35
Change
+$0.18 (+1.27%)
Updated
Jun 2 closing price
Net Assets
385.88M
UBVVX
Price
$84.04
Change
+$0.45 (+0.54%)
Updated
Jun 2 closing price
Net Assets
8.91B
Interact to see
Advertisement

LRSPX vs UBVVX

Header iconLRSPX vs UBVVX Comparison
Open Charts LRSPX vs UBVVXBanner chart's image
LRSPX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
LRSPX vs. UBVVX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRSPX is a Hold and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 8.91B vs. LRSPX (386M). UBVVX pays higher dividends than LRSPX: UBVVX (1.68) vs LRSPX (0.14). LRSPX was incepted earlier than UBVVX: LRSPX (27 years) vs UBVVX (9 years). LRSPX (1.41) is less costly to investors than UBVVX (0.94). LRSPX is a more actively managed with annual turnover of: 69.00 vs. UBVVX (35.00). LRSPX (0) and UBVVX (0) have matching initial minimum investment requirements. LRSPX annual gain was more profitable for investors over the last year : 15.47 vs. UBVVX (7.97). UBVVX return over 5 years is better than : 4.89 vs. LRSPX (-16.96).
LRSPXUBVVXLRSPX / UBVVX
Total Expense Ratio1.410.90157%
Annual Report Gross Expense Ratio1.410.94150%
Fund Existence27 years9 years-
Gain YTD10.7036.934154%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets386M8.91B4%
Annual Yield % from dividends0.141.688%
Returns for 1 year15.477.97194%
Returns for 3 years16.8018.2692%
Returns for 5 years-16.964.89-347%
Returns for 10 years-32.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLGT18.700.61
+3.37%
Fulgent Genetics
FGL2.070.06
+2.99%
Founder Group Limited
APLD47.86-0.08
-0.17%
Applied Digital Corp
CHA12.71-0.48
-3.64%
Chagee Holdings Ltd
ANIX2.57-0.14
-5.00%
Anixa Biosciences